Table 2.
PGD (n=86) | No PGD (n=229) | P Value | |
---|---|---|---|
Diagnosis | <0.01 | ||
COPD | 26 (30%) | 127 (55%) | |
CF | 5 (6%) | 29 (13%) | |
IPF | 38 (44%) | 59 (26%) | |
Other | 17 (20%) | 14 (6%) | |
Recipient Race | <0.01 | ||
Caucasian | 68 (79%) | 208 (75%) | |
African American | 15 (17%) | 10 (4%) | |
Hispanic | 1 (1%) | 6 (3%) | |
Asian American | 1 (1%) | 1 (1%) | |
Other | 1 (1%) | 4 (2%) | |
Female Recipient | 42 (49%) | 108 (47%) | 0.07 |
Recipient Age | 53 ± 12 | 53 ± 12 | 0.67 |
Donor Race | 0.21 | ||
Caucasian | 61 (73%) | 150 (66%) | |
African American | 10 (12%) | 48 (21%) | |
Hispanic | 10 (12%) | 24 (11%) | |
Asian American | 1 (1%) | 4 (2%) | |
Other | 2 (2%) | 1 (1%) | |
Female Donor | 40 (47%) | 87 (38%) | 0.08 |
Donor Age | 35 ± 14 | 33 ± 14 | 0.19 |
Bilateral Transplant | 50 (58%) | 128 (72%) | 0.73 |
Use of CBP | 49 (57%) | 59 (26%) | <0.01 |
CBP TIME (min) | 239 ± 84 | 223 ± 74 | 0.31 |
Mean PASP | 53± 26 | 38 ± 13 | <0.01 |
COPD=Chronic Obstructive Lung Disease, IPF=Idiopathic Pulmonary Fibrosis, CF= cystic fibrosis, CBP=cardiopulmonary bypass.